BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 178 filers reported holding BLUEBIRD BIO INC in Q1 2023. The put-call ratio across all filers is 0.92 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,357,545 | +3.5% | 412,628 | 0.0% | 0.22% | -27.5% |
| Q1 2023 | $1,312,157 | -76.7% | 412,628 | -49.2% | 0.30% | -78.0% |
| Q4 2022 | $5,623,385 | +92.1% | 812,628 | +75.7% | 1.36% | +132.8% |
| Q3 2022 | $2,928,000 | +292700.0% | 462,628 | +151085.6% | 0.58% | – |
| Q1 2022 | $1,000 | -50.0% | 306 | +6.6% | 0.00% | – |
| Q4 2021 | $2,000 | -99.9% | 287 | -99.7% | 0.00% | -100.0% |
| Q1 2021 | $3,211,000 | -30.3% | 106,481 | 0.0% | 0.11% | -47.1% |
| Q4 2020 | $4,607,000 | +112.0% | 106,481 | +164.3% | 0.20% | +29.9% |
| Q3 2020 | $2,173,000 | -74.5% | 40,281 | -71.2% | 0.16% | -76.9% |
| Q2 2020 | $8,538,000 | +142.8% | 139,874 | +82.8% | 0.68% | +157.2% |
| Q1 2020 | $3,516,000 | – | 76,498 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Monashee Investment Management LLC | 125,000 | $13,131,000 | 5.55% |
| Cormorant Asset Management, LP | 275,000 | $28,889,000 | 4.79% |
| Eventide Asset Management | 569,700 | $59,847,000 | 3.73% |
| Crosspoint Capital Strategies, LLC | 28,937 | $3,040,000 | 2.66% |
| Casdin Capital, LLC | 65,000 | $6,828,000 | 2.53% |
| ARK Investment Management | 119,683 | $12,573,000 | 2.45% |
| RTW INVESTMENTS, LP | 104,383 | $10,965,000 | 2.31% |
| Taylor Wealth Management Partners | 38,368 | $4,031,000 | 1.82% |
| First Light Asset Management, LLC | 33,780 | $3,549,000 | 1.19% |
| Atika Capital Management LLC | 25,000 | $2,627,000 | 0.92% |